دورية أكاديمية
Safety, biodistribution, pharmacokinetics, and immunogenicity of 99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck
العنوان: | Safety, biodistribution, pharmacokinetics, and immunogenicity of 99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck |
---|---|
المؤلفون: | Colnot, David R., Roos, Jan C., de Bree, Remco, Wilhelm, Abraham J., Kummer, J. Alain, Hanft, Gertraud, Heider, Karl-Heinz, Stehle, Gerd, Snow, Gordon B., van Dongen, Guus A. M. S. |
المصدر: | Cancer Immunology, Immunotherapy. September 2003 52(9):576-582 |
قاعدة البيانات: | Springer Nature Journals |
تدمد: | 03407004 14320851 |
---|---|
DOI: | 10.1007/s00262-003-0396-5 |